Study
Acarbose - StatPearls
PRIMARY
2023
Summary Does acarbose help people live longer or stay healthier? Show / hide ↓
This 2023 clinical reference summarizes how acarbose is used, rather than reporting a new study with participants. Acarbose is a prescription diabetes medicine that slows the digestion of carbohydrates, helping reduce blood sugar spikes after meals. It can modestly improve blood sugar in people with type 2 diabetes, but often causes gas, bloating, or diarrhea. This source does not provide direct evidence that acarbose extends human lifespan.
What this means for you: Do not buy or take acarbose for longevity based on this source. It may be useful for some people with diabetes, but a clinician should decide whether it is appropriate.
weak evidenceDesignPRIMARY
TierTier 5, Mechanistic / animal / marketing
Year2023
JournalNCBI Bookshelf, StatPearls Publishing
Added to NO1GEVITYAug 4, 2026
Evidence Trail
Follow the chain
From this page back to the goal it moves.
IngredientAcarboseprescription drug (alpha-glucosidase inhibitor)←MechanismInsulin/IGF-1 Signaling in AgingThe insulin/IGF-1 signaling pathway couples nutrient availabilit←GoalApolipoprotein B (ApoB)The structural protein on every atherogenic lipoprotein particle←StudyAcarbose - StatPearlsNCBI Bookshelf, StatPearls Publishing 2023
See the full chain on the Longevity Map →Cited by
1 encyclopedia entries reference this study.